| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 11/24/2010 | EP2252370A1 Use of lipid-rich nutrition for the treatment of post-operative ileus |
| 11/24/2010 | EP2252325A2 Treatment of pompe disease with specific pharmacological chaperones and monitoring treatment using surrogate markers |
| 11/24/2010 | EP2252324A1 Method for increasing the activity of the immune system of a mammal at risk of inflammatory diseases |
| 11/24/2010 | EP2252323A2 Genetic regulation of host defense mechanisms by mucosal exposure to natural interferon alpha species |
| 11/24/2010 | EP2252322A2 Vaccine compositions |
| 11/24/2010 | EP2252321A2 Treatment and prevention of cardiac conditions using two or more isoforms of hepatocyte growth factor |
| 11/24/2010 | EP2252320A2 Use of anti-connexin polynucleotides and peptides for the treatment of abnormal or excessive scars |
| 11/24/2010 | EP2252319A2 Methods for modulating a population of myeloid-derived suppressor cells and uses thereof |
| 11/24/2010 | EP2252318A2 Methods of treating inflammation |
| 11/24/2010 | EP2252317A2 A humanized model of membrane attack complex (mac) formation on murine retina and compositions, kits and methods for treatment of macular degeneration |
| 11/24/2010 | EP2252316A2 Modulation of adenoviral tropism |
| 11/24/2010 | EP2252315A1 Improved antitumoral treatments |
| 11/24/2010 | EP2252314A2 Leptin agonist and methods of use |
| 11/24/2010 | EP2252313A2 Method to predict response to pharmacological chaperone treatment of diseases |
| 11/24/2010 | EP2252312A2 Methods for preventing or treating insulin resistance |
| 11/24/2010 | EP2252311A1 Heteroaryl-containing tripeptide hcv serine protease inhibitors |
| 11/24/2010 | EP2252310A1 Heterocyclic peptide ketoamides |
| 11/24/2010 | EP2252275A2 Templated open flocs of anisotropic particles for enhanced pulmonary delivery |
| 11/24/2010 | EP1913400B1 Il-32 modulators |
| 11/24/2010 | EP1780270B1 A detoxifizyme having activity of transforming aflatoxin and the gene encodes thereof |
| 11/24/2010 | EP1755652B1 Factor ixa for the treatment of bleeding disorders |
| 11/24/2010 | EP1608751B1 Method for the in vivo modification of the synthesis activity of a metabolite by means of the modification of a gene the activity of which is not the original activity |
| 11/24/2010 | EP1527088B1 Pegylated t20 polypeptide |
| 11/24/2010 | EP1502949B1 Antimicrobial polypeptide and utilization thereof |
| 11/24/2010 | EP1443954B1 Targeted thrombosis by tissue factor polypeptides |
| 11/24/2010 | EP1438418B1 Stem cells of the islets of langerhans and their use in treating diabetes mellitus |
| 11/24/2010 | EP1385948B1 Nucleic acids for inhibiting hairless protein expression and methods of use thereof |
| 11/24/2010 | EP1381375B1 Oligonucleotide compositions and their use to induce differentiation of cells |
| 11/24/2010 | EP1355919B1 Molecules with extended half-lives, compositions and uses thereof |
| 11/24/2010 | EP1298439B1 Method for screening mch receptor antagonist/agonist |
| 11/24/2010 | EP1119371B1 Flt4 (VEGFR-3) AS A TARGET FOR TUMOR IMAGING AND ANTI-TUMOR THERAPY |
| 11/24/2010 | EP0804572B1 Fusion protein comprising bpTK7 |
| 11/24/2010 | EP0444181B2 C-erbb-2 external domain: gp75 |
| 11/24/2010 | CN1958610B Medication of guiding antibody for anti leukaemia in monocarpotic cellularity |
| 11/24/2010 | CN1935253B Cerebral proteolysis dispersible tablet and its preparing method |
| 11/24/2010 | CN1927879B Thymopentapeptide active isomer and application thereof in pharmaceutical preparation |
| 11/24/2010 | CN1921896B Haemostatic sprays and compositions |
| 11/24/2010 | CN1919870B Cat alpha interferon, encode gene and application thereof |
| 11/24/2010 | CN1860371B Protein kinase C zeta as a drug target for arthritis and other inflammatory diseases |
| 11/24/2010 | CN1816564B Rasgap derived peptide for selectively killing cancer cells |
| 11/24/2010 | CN1727014B Method for processing blood using medicine containing enkephalin of methionine |
| 11/24/2010 | CN101896501A Antibody targeting osteoclast-related protein Siglec-15 |
| 11/24/2010 | CN101896500A Immune modulation via C-type lectin |
| 11/24/2010 | CN101896499A Compositions and methods of using proislet peptides and analogs thereof |
| 11/24/2010 | CN101896193A An agent for reducing a side effect of an anticancer drug |
| 11/24/2010 | CN101896192A A method of treating cachexia with the removal or inactivation of macrophage inhibitory cytokine-1 |
| 11/24/2010 | CN101896191A System for delivery into a XCR1 positive cell and uses thereof |
| 11/24/2010 | CN101896190A Treatment of melanoma with alpha thymosin peptides in combination with antibodies against cytotoxic t lymphocyte-associated antigen 4 (CTLA4) |
| 11/24/2010 | CN101896186A Means and methods for counteracting muscle disorders |
| 11/24/2010 | CN101896160A Cyclosporin compositions |
| 11/24/2010 | CN101892252A Gene for encoding muramidase and application of same |
| 11/24/2010 | CN101892240A Japanese blood fluke beta-catenin gene, protein and application |
| 11/24/2010 | CN101892239A Schistosoma japonicum katsurada Frizzled 9 gene, protein and use |
| 11/24/2010 | CN101892237A Polynucleotide related to mitochondrial membrane potential decrease and coded polypeptide and application thereof |
| 11/24/2010 | CN101892210A Sipunculus nudus plasmin and preparation method thereof |
| 11/24/2010 | CN101892177A Antifungal lipopeptid-containing skin liniment and preparation method thereof |
| 11/24/2010 | CN101892176A Microbe generating antifungal lipopeptid and preparation method and application of antifungal lipopeptid thereof |
| 11/24/2010 | CN101891826A Targeted hIL-10 recombinant protein and application thereof |
| 11/24/2010 | CN101891823A Exendin-4 and analog fusion protein thereof |
| 11/24/2010 | CN101891822A Fusion polypeptide use for preventing and treating senile dementia by brain barrier permeability |
| 11/24/2010 | CN101891812A Mechano growth factor polypeptide, preparation method and application thereof |
| 11/24/2010 | CN101891811A Shark angiogenesis inhibiting factor and production and purification method and application |
| 11/24/2010 | CN101891809A Preparation and application of phycocyanin extract |
| 11/24/2010 | CN101891807A Canola protein isolate compositions |
| 11/24/2010 | CN101891804A Antisense peptide nucleic acid of cell penetrating peptide-mediated antibacterial RNA polymerase sigma 70 factor gene rpoD |
| 11/24/2010 | CN101891802A Polypeptide or derivative product for treating or preventing cancer and application thereof |
| 11/24/2010 | CN101891801A Saturated aliphatic chain alcohol RGD (Arginyl-Glycyl-Aspartic acid) pentapeptide diester compound, synthesis method and application thereof |
| 11/24/2010 | CN101891800A Saturated aliphatic chain alcohol RGD pentapeptide ester compound, synthetic method and application thereof |
| 11/24/2010 | CN101890181A Swine fibrin glue powder inhalation and preparation method and application thereof |
| 11/24/2010 | CN101890168A Biodegradable block copolymeric compositions for drug delivery |
| 11/24/2010 | CN101890158A Prescription and preparation method of mixture for tonifying stomach and promoting digestion |
| 11/24/2010 | CN101890157A Application of gastrin in inhibiting gastrointestinal tumor tumors |
| 11/24/2010 | CN101890156A Receptor-selective lymphotoxin (LT) derivative |
| 11/24/2010 | CN101890155A Medicinal composition and application thereof |
| 11/24/2010 | CN101890154A Application of cobra short-chain neurotoxin in preparation of immunosuppressive drugs |
| 11/24/2010 | CN101890153A Method for treating chronic liver diseases by using hepatocyte nuclear factor-4alpha (HNF4alpha) |
| 11/24/2010 | CN101890152A Application of Chinese yam glycoprotein in preparation of antihypoxic and antifatigue medicaments |
| 11/24/2010 | CN101890151A Application of corn oligopeptide preparation in preparation of medicaments for reducing blood pressure and healthcare foods |
| 11/24/2010 | CN101890046A Composition with heart rate reducing properties |
| 11/24/2010 | CN101889983A PEG-PLGA nanoparticle carrying recombinant human vascular endothelial inhibitor and preparation method thereof |
| 11/24/2010 | CN101259115B Orally-administered insulin soft capsule for treating diabetes and preparation thereof |
| 11/24/2010 | CN101215324B Exenatide short peptide simulation peptide and application thereof in preparing medicament for curing diabetes |
| 11/24/2010 | CN101143890B New born calf brain active peptide, preparation method and application thereof in preparing anti-cancer medicament |
| 11/24/2010 | CN101139393B KDR peptides and vaccines containing the same |
| 11/24/2010 | CN101011569B Method for diagnosing and treating type II dentinogenesis by using DSPP gene and encoding product thereof |
| 11/23/2010 | US7838664 used as modulators or targets of developmental processes or disorders associated with developmental dysfunctions, such as cancer; tumor suppressors genes |
| 11/23/2010 | US7838663 used as modulators or targets of developmental processes or disorders associated with developmental dysfunctions, such as cancer; tumor suppressors genes |
| 11/23/2010 | US7838662 used as modulators or targets of developmental processes or disorders associated with developmental dysfunctions, such as cancer; tumor suppressors genes |
| 11/23/2010 | US7838661 used as modulators or targets of developmental processes or disorders associated with developmental dysfunctions, such as cancer; tumor suppressors genes |
| 11/23/2010 | US7838660 used as modulators or targets of developmental processes or disorders associated with developmental dysfunctions, such as cancer; tumor suppressors genes |
| 11/23/2010 | US7838648 Purified SR-p70 protein |
| 11/23/2010 | US7838645 Function of autophagy genes in cell death |
| 11/23/2010 | US7838639 antibody that specifically binds to a human TNF Receptor in the BRAIN (TRAIN) polypeptide; useful in regulating cell differentiation, death, and survival |
| 11/23/2010 | US7838637 Single-chain multiple antigen-binding molecule, its preparation and use |
| 11/23/2010 | US7838630 for repairing a ruptured anterior cruciate ligament; reproduces the function of the fibrin clot to re-connect extra-articular tissues in the early phase of healing |
| 11/23/2010 | US7838595 high purity; storage stability; electrophilically activated polymer derivatives with aldehyde functionality for conjugating to biologically active molecules; drug-polymer conjugate; |
| 11/23/2010 | US7838561 administering to mammal or higher vertebrate an effective amount of a pharmaceutical composition comprising N-[4-hydroxyphenyl]retinamide |
| 11/23/2010 | US7838560 Urokinase inhibitors, production and use thereof |
| 11/23/2010 | US7838510 Biomaterials based on hyaluronic acid for the anti-angiogenic therapy in the treatment of tumors |
| 11/23/2010 | US7838506 nonpeptidic inhibitors of cathepsin G; genetic diseases, degenerative diseases, DNA damages, neoplasia and/or skin diseases; DNA or polynucleotide sequences having a chain length of at least 60 nucleotides and being substantially not subjected to undergo efficient base pairing |